Author: NDORMS, University of Oxford
Source: Medical Xpress
Publish date: March 17, 2025
New guidelines establish framework for trustworthy AI in health care
A new set of guidelines has been launched to create trustworthy AI systems in health care. The first of its kind, the FUTURE-AI guideline provides recommendations covering the entire lifecycle of medical AI, from design, development and validation to regulation, deployment, and monitoring.
In recent years, artificial intelligence (AI) has made significant strides in health care, helping with tasks like disease diagnosis and predicting treatment outcomes. However, despite these advances, many health care professionals and patients are still hesitant to fully embrace AI technologies. This hesitation largely stems from concerns about trust, safety, and ethics.
In particular, existing research has shown that AI tools in health care can be prone to errors and patient harm, biases and increased health inequalities, lack of transparency and accountability, as well as data privacy and security breaches.
To overcome these challenges, the FUTURE-AI Consortium has developed a comprehensive set of guidelines published in the BMJ. Developed by an international consortium of 117 experts from 50 countries, the new guidelines called FUTURE-AI provide a roadmap for creating trustworthy and responsible AI tools for health care.
The FUTURE-AI guidelines are built around six guiding principles:
- Fairness: AI should treat all patients equitably and without bias.
- Universality: AI solutions should be applicable across different health care contexts and populations.
- Traceability: It should be possible to track how AI systems make decisions.
- Usability: AI tools must be user-friendly for health care professionals and patients alike.
- Robustness: AI systems should perform reliably under various conditions.
- Explainability: Patients and clinicians need clear explanations of how AI arrives at its conclusions.
Gary Collins, Professor of Medical Statistics at the Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, and author of FUTURE-AI said, “These guidelines fill an important gap in the field of health care AI to give clinicians, patients, and health authorities the confidence to adopt AI tools knowing they are technically sound, clinically safe, and ethically aligned. The FUTURE-AI framework is designed to evolve over time, adapting to new technologies, challenges, and stakeholder feedback. This dynamic approach ensures the guidelines remain relevant and useful as the field of health care AI continues to rapidly advance.”
More information
This article was from Medical Xpress and was licensed to Novartis for Novartis’ use by the Industry Dive Content Marketplace. Please direct all licensing questions to [email protected].
Related content
UK | April 2026 | FA-11628072
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Novartis online through the pharmacovigilance intake (PVI) tool at www.novartis.com/report, or alternatively email [email protected] or call 01276 698370.
